Cambridge Healthtech Institute’s 11^th International

Leaders in Biobanking Congress

Innovations to Maintain Integrity and Maximize Investment in Biospecimens

October 30–November 1, 2019

Human biospecimens (tissues and fluids) are an essential foundation for effective translational and genomics-based research and have proven to be critical for the development of personalized medicine. The demand for high quality and clinically annotated biospecimens and the challenge of finding them to conduct clinical research or validation studies has grown rapidly, primarily due to an unprecedented level of genomic, post-genomic and personalized medicine research. The increased complexity of biospecimen requests in terms of linked pre-clinical variables, biospecimen types, and multidimensional longitudinal clinical follow-up data has created new challenges but also opportunities for adapting collection and annotation strategies to meet the biospecimen supply needs of the future.

Cambridge Healthtech Institute’s Eleventh International Leaders in Biobanking Congress addresses innovations in biospecimen science and infrastructure to support expanding applications. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.

Innovations covered include:

Those encouraged to submit a title and summary of their experiences for consideration of presentation include:

• Molecular researchers utilizing biospecimens for their research
• Biobankers providing biospecimens, developing biopreservation technologies standards and protocols, and managing resources while navigating regulatory compliance
• R&D researchers and clinical trial professionals collecting, analyzing, and utilizing data

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is April 19, 2019.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mary Ann Brown

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781-972-5497
Email: mabrown@healthtech.com

For partnering and sponsorship information, please contact:

Katelin Fitzgerald

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com